Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Neurology

The Medication Roadmap: Finding Relief and Staying Safe

At a Glance

Carbamazepine and oxcarbazepine are the most effective first-line medications for trigeminal neuralgia, working to calm hyper-excitable nerves. Doses should be increased slowly to minimize dizziness, and some patients require genetic screening or regular blood tests to ensure safety.

Medication is the first line of defense against trigeminal neuralgia (TN). Unlike typical over-the-counter painkillers (like ibuprofen or acetaminophen), which are generally ineffective for TN, specific “membrane-stabilizing” medications are used to calm the hyper-excitable nerve [1][2].

First-Line Therapy: The Gold Standard

Clinical guidelines from the European Academy of Neurology (EAN) and the American Academy of Neurology (AAN) identify two primary medications as the “gold standard” for TN [3][2]:

  1. Carbamazepine: This is the most extensively studied and effective medication for TN [4]. It works by blocking sodium channels in the nerve, preventing the “short circuit” that causes pain [1].
  2. Oxcarbazepine: Often preferred by clinicians because it is typically better tolerated than carbamazepine and has fewer interactions with other drugs [5][6].

Titration (Low and Slow): To minimize side effects, your doctor should use a “low and slow” approach. This means starting at a very low dose and gradually increasing it over several weeks so your brain can adjust to side effects like dizziness and brain fog [2].

Critical Safety Note: Before starting carbamazepine or oxcarbazepine, patients of Asian descent should be screened for a genetic marker called HLA-B*15:02 [7][8]. Carrying this gene significantly increases the risk of a rare but life-threatening skin reaction called Stevens-Johnson Syndrome (SJS) [9][10].

Second-Line and Add-On Options

If first-line medications are not fully effective or cause too many side effects, your doctor may suggest “add-on” therapies [11][12]:

  • Baclofen: A muscle relaxant that can help suppress nerve signals; it is often used in combination with carbamazepine [13].
  • Gabapentin or Pregabalin: Often used if you have “concomitant continuous pain” (a background ache) in addition to the sharp shocks [14].
  • Lamotrigine: Another anti-seizure medication that can be effective but must be increased very slowly to avoid rashes [2].
  • Botulinum Toxin A (Botox): Injections into the trigger zones on the face have been shown to reduce pain frequency and intensity for several months [15][16].

Managing a Pain Crisis (ER Protocol)

A TN “pain crisis” occurs when attacks become so frequent or severe that you cannot eat, drink, or speak. This is a medical emergency. If you go to the Emergency Room, the following treatments may be used to “break” the cycle [17][18]:

  • IV Fosphenytoin: An intravenous anti-seizure medication that can provide rapid, temporary relief, acting as a “bridge” until your oral medications can be adjusted [19][20].
  • IV Lidocaine Infusion: Under careful monitoring, a lidocaine drip can help stabilize the nerve during a severe flare [21][22].

Tip: Bring your MRI reports or a letter from your neurologist to the Emergency Room to help staff quickly understand your diagnosis and expedite IV protocols.

Common Side Effects to Monitor

All TN medications require a balance between pain control and side effects. You should have regular blood work to monitor for:

  • Complete Blood Count (CBC): Carbamazepine carries an FDA Black Box Warning for rare but severe blood disorders (like aplastic anemia). You need regular tests to monitor your white blood cells and platelets. Report any unexplained fevers, sore throats, or easy bruising immediately [23][4].
  • Hyponatremia: Low blood sodium, which can cause confusion or unsteadiness, especially in older adults [12][11].
  • Liver Function: Some medications can affect liver enzymes over time [24].
  • Bone Density: Long-term use of anti-seizure medications can affect bone health, so periodic monitoring for osteopenia or osteoporosis is advisable [2].

Common questions in this guide

Why don't normal painkillers work for trigeminal neuralgia?
Over-the-counter painkillers like ibuprofen or acetaminophen are generally ineffective for trigeminal neuralgia. Because TN is caused by a hyper-excitable nerve, specific membrane-stabilizing medications are required to calm the nerve and block the pain signals.
What are the best medications for trigeminal neuralgia?
The gold standard first-line medications for TN are carbamazepine and oxcarbazepine. These anti-seizure medications block sodium channels in the nerve to prevent the short circuits that cause sharp, shock-like facial pain.
Why do I need a genetic test before starting carbamazepine?
Patients of Asian descent should be screened for the HLA-B*15:02 genetic marker before starting carbamazepine or oxcarbazepine. Carrying this gene significantly increases the risk of a rare, life-threatening skin reaction called Stevens-Johnson Syndrome.
What should I do if I have a trigeminal neuralgia pain crisis and can't swallow pills?
A severe pain crisis where you cannot eat or drink is a medical emergency. Go to the Emergency Room, where doctors can administer intravenous treatments like IV fosphenytoin or a lidocaine drip to provide rapid relief until your oral medications can be adjusted.
What side effects should I watch for when taking TN medications?
Common side effects include dizziness and brain fog, which can often be managed by slowly increasing your dose over time. However, you should seek immediate medical attention if you develop new skin rashes, unexplained fevers, mouth sores, or easy bruising.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my ancestry, should I be screened for the HLA-B*15:02 or HLA-A*31:01 genetic markers before starting carbamazepine?
  2. 2.How often do I need blood tests to monitor my sodium levels, liver function, and complete blood count (CBC)?
  3. 3.What is the target dose for my medication, and how slowly should we titrate (increase) it to minimize side effects?
  4. 4.If I experience a 'pain crisis' and can't swallow my pills, which local ER should I go to that is familiar with IV fosphenytoin or lidocaine protocols?
  5. 5.If we add a second medication like baclofen or gabapentin, what specific drug interactions should we watch for?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments.

    Gambeta E, Chichorro JG, Zamponi GW

    Molecular pain 2020; (16()):1744806920901890 doi:10.1177/1744806920901890.

    PMID: 31908187
  2. 2

    Real-world effectiveness and tolerability of carbamazepine and oxcarbazepine in 354 patients with trigeminal neuralgia.

    Di Stefano G, De Stefano G, Leone C, et al.

    European journal of pain (London, England) 2021; (25(5)):1064-1071 doi:10.1002/ejp.1727.

    PMID: 33428801
  3. 3

    European Academy of Neurology guideline on trigeminal neuralgia.

    Bendtsen L, Zakrzewska JM, Abbott J, et al.

    European journal of neurology 2019; (26(6)):831-849 doi:10.1111/ene.13950.

    PMID: 30860637
  4. 4

    Safety and efficacy of carbamazepine in the treatment of trigeminal neuralgia: A metanalysis in biomedicine.

    Guo M, Shen W, Zhou M, et al.

    Mathematical biosciences and engineering : MBE 2024; (21(4)):5335-5359 doi:10.3934/mbe.2024235.

    PMID: 38872538
  5. 5

    Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B*15:02.

    Stancil SL, Sandritter T, Strawn JR

    Journal of child and adolescent psychopharmacology 2024; (34(1)):61-66 doi:10.1089/cap.2023.0064.

    PMID: 38377523
  6. 6

    Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells.

    Sugiyama I, Murayama N, Kuroki A, et al.

    Xenobiotica; the fate of foreign compounds in biological systems 2016; (46(9)):765-74 doi:10.3109/00498254.2015.1118774.

    PMID: 26711482
  7. 7

    Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: An updated meta-analysis.

    Biswas M, Ershadian M, Shobana J, et al.

    Clinical and translational science 2022; (15(8)):1887-1905 doi:10.1111/cts.13291.

    PMID: 35599240
  8. 8

    Impact on carbamazepine usage and cutaneous adverse reactions before and after the reimbursement of HLA-B*1502 genotyping in Taiwan, 2000-2017: A nationwide longitudinal study.

    Chang BL, Liu JR, Chang SH, See LC

    Epilepsia 2023; (64(10)):2679-2689 doi:10.1111/epi.17726.

    PMID: 37506179
  9. 9

    Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed Medications.

    Lo C, Nguyen S, Yang C, et al.

    Clinical and translational science 2020; (13(5)):861-870 doi:10.1111/cts.12771.

    PMID: 32100936
  10. 10

    Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care.

    Sung C, Tan L, Limenta M, et al.

    Frontiers in pharmacology 2020; (11()):527 doi:10.3389/fphar.2020.00527.

    PMID: 32457602
  11. 11

    Oxcarbazepine for trigeminal neuralgia may induce lower extremity weakness: A case report.

    Song HG, Nahm FS

    World journal of clinical cases 2020; (8(5)):922-927 doi:10.12998/wjcc.v8.i5.922.

    PMID: 32190628
  12. 12

    Hyponatremia-induced worsening of trigeminal neuralgia- When the sodium plays the game.

    Ansari MZ, Singh R, Mohanty B, et al.

    Journal of family medicine and primary care 2024; (13(1)):378-380 doi:10.4103/jfmpc.jfmpc_1187_23.

    PMID: 38482311
  13. 13

    GABAB receptor activation attenuates inflammatory orofacial pain by modulating interleukin-1β in satellite glial cells: Role of NF-κB and MAPK signaling pathways.

    Liu F, Zhang YY, Song N, et al.

    Brain research bulletin 2019; (149()):240-250 doi:10.1016/j.brainresbull.2019.04.018.

    PMID: 31034945
  14. 14

    Considerations When Using Gabapentinoids to Treat Trigeminal Neuralgia: A Review.

    De Stefano G, Di Pietro G, Truini A, et al.

    Neuropsychiatric disease and treatment 2023; (19()):2007-2012 doi:10.2147/NDT.S407543.

    PMID: 37745191
  15. 15

    Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA.

    Asan F, Gündüz A, Tütüncü M, et al.

    Headache 2022; (62(10)):1322-1328 doi:10.1111/head.14414.

    PMID: 36437599
  16. 16

    Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.

    Yoshida K

    Toxins 2021; (13(9)) doi:10.3390/toxins13090605.

    PMID: 34564609
  17. 17

    Intravenous fosphenytoin therapy for the rescue of acute trigeminal neuralgia crisis in pre- and post-neurosurgical patients: a retrospective observational study.

    Noro S, Endo H, Asayama B, et al.

    Frontiers in neurology 2024; (15()):1493274 doi:10.3389/fneur.2024.1493274.

    PMID: 39839861
  18. 18

    Intravenous fosphenytoin as treatment for acute exacerbation of trigeminal neuralgia: A prospective systematic study of 15 patients.

    Andersen ASS, Heinskou TB, Asghar MS, et al.

    Cephalalgia : an international journal of headache 2022; (42(11-12)):1138-1147 doi:10.1177/03331024221094536.

    PMID: 35469443
  19. 19

    In-Hospital Management of Acute Trigeminal Neuralgia Pain Crises.

    Chow A, Haider I, Athanaselos A, Patel M

    Clinical medicine & research 2024; (22(4)):215-221 doi:10.3121/cmr.2024.1945.

    PMID: 39993829
  20. 20

    Low-dose Fosphenytoin for Aborting Acute Trigeminal Neuralgia Pain: A Case Report.

    Baydoun J, Lin A, Miya J

    Clinical practice and cases in emergency medicine 2023; (7(3)):182-184 doi:10.5811/cpcem.1603.

    PMID: 37595315
  21. 21

    Lidocaine infusion for the treatment of intractable trigeminal neuralgia: retrospective case series and systematic review.

    Mohamed MW, Irem-Oko F, Sheikh A, et al.

    Acta neurochirurgica 2025; (167(1)):259 doi:10.1007/s00701-025-06672-8.

    PMID: 41021111
  22. 22

    Treatment of acute exacerbations of trigeminal neuralgia in the emergency department: A retrospective case series.

    Pinto MJ, Gomes A, Pinto M, et al.

    Headache 2022; (62(8)):1002-1006 doi:10.1111/head.14373.

    PMID: 36005285
  23. 23

    Stevens-Johnson Syndrome following Failure of Genetic Screening prior to Carbamazepine Prescription.

    Nasir SA, Tan HL, Tan HJ, et al.

    Case reports in dentistry 2017; (2017()):4201357 doi:10.1155/2017/4201357.

    PMID: 28473929
  24. 24

    A Retrospective Analysis of Medical Management Strategies for Trigeminal Neuralgia: An Institutional Review.

    Murugesan I, T N U, Ramalingam K

    Cureus 2024; (16(9)):e69258 doi:10.7759/cureus.69258.

    PMID: 39398659

This page explains trigeminal neuralgia medications for educational purposes only. Always consult your neurologist before starting, stopping, or adjusting your TN treatment.

Get notified when new evidence is published on Trigeminal neuralgia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.